# FDA Inspection 1119387 - OMRIX Biopharmaceuticals LTD - February 24, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/omrix-biopharmaceuticals-ltd/bf341e84-337e-4387-823b-89fd22737bad
Source feed: FDA_Inspections

> FDA Inspection 1119387 for OMRIX Biopharmaceuticals LTD on February 24, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1119387
- Company Name: OMRIX Biopharmaceuticals LTD
- Inspection Date: 2020-02-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 812014 - 2012-11-05](https://www.globalkeysolutions.net/records/fda_inspections/omrix-biopharmaceuticals-ltd/b8074cd8-d4bd-4323-b2fc-69cbd93bfa11)
- [FDA Inspection 635392 - 2009-10-29](https://www.globalkeysolutions.net/records/fda_inspections/omrix-biopharmaceuticals-ltd/8dafa35c-f007-4b47-9e70-7380cf03a7fc)

Company: https://www.globalkeysolutions.net/companies/omrix-biopharmaceuticals-ltd/bf1b8f1e-b1c7-47be-bb38-f85e1cff944d

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d